Business Description
PharmaLundensis AB
NAICS : 325412
SIC : 2834
ISIN : SE0003359710
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.2 | |||||
Debt-to-Equity | 2.66 | |||||
Debt-to-EBITDA | -2.35 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 24.9 | |||||
3-Year EPS without NRI Growth Rate | 21.4 | |||||
3-Year Book Growth Rate | -38 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.91 | |||||
9-Day RSI | 53.78 | |||||
14-Day RSI | 52.3 | |||||
6-1 Month Momentum % | 56.44 | |||||
12-1 Month Momentum % | 61.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.43 | |||||
Quick Ratio | 0.43 | |||||
Cash Ratio | 0.32 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.1 | |||||
Shareholder Yield % | -11.05 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -137.97 | |||||
ROA % | -35.71 | |||||
ROIC % | -30.43 | |||||
ROC (Joel Greenblatt) % | -830.77 | |||||
ROCE % | -42.03 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 16.56 | |||||
EV-to-EBIT | -11.75 | |||||
EV-to-EBITDA | -17.07 | |||||
EV-to-FCF | -12.49 | |||||
Earnings Yield (Greenblatt) % | -8.51 | |||||
FCF Yield % | -8.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
PharmaLundensis AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -0.094 | ||
Beta | -0.02 | ||
Volatility % | 123.51 | ||
14-Day RSI | 52.3 | ||
14-Day ATR (kr) | 0.086712 | ||
20-Day SMA (kr) | 0.7512 | ||
12-1 Month Momentum % | 61.86 | ||
52-Week Range (kr) | 0.142874 - 1.4 | ||
Shares Outstanding (Mil) | 42.19 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PharmaLundensis AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PharmaLundensis AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
PharmaLundensis AB Frequently Asked Questions
What is PharmaLundensis AB(XSAT:PHAL)'s stock price today?
When is next earnings date of PharmaLundensis AB(XSAT:PHAL)?
Does PharmaLundensis AB(XSAT:PHAL) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |